Related Experiment Video
Updated: Dec 4, 2025
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Ferroptosis in Cancer Treatment: Another Way to Rome
Yinan Wu1,2, Chengcheng Yu3, Meng Luo1,2
1Department of Breast Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Abstract:
Ferroptosis is a newly described type of programmed cell death and intensively related to both maintaining homeostasis and the development of diseases, especially cancers. Inducing ferroptosis leads to mitochondrial dysfunction and toxic lipid peroxidation in cells, which plays a pivotal role in suppressing cancer growth and progression. Here, we reviewed the existing studies about the molecular mechanisms of ferroptosis involved in different antitumor treatments, such as chemotherapy, targeted therapy, radiotherapy, and immunotherapy. We focused in particular on the distinct combinatorial therapeutic effects such as the synergistic sensitization effect and the drug-resistance reversal achieved when using ferroptosis inducers with conventional cancer therapy. Finally, we discussed the challenges and opportunities in clinical applications of ferroptosis. The application of nanotechnolgy and other novel technologies may provide a new direction in ferroptosis-driven cancer therapies.
Insights
Ferroptosis, a programmed cell death, shows promise in cancer therapy by inducing cell dysfunction. Combining ferroptosis inducers with conventional treatments may enhance efficacy and overcome drug resistance.
Area of Science:
- Biomedical Science
- Molecular Biology
- Cancer Research
Background:
- Ferroptosis is a distinct form of programmed cell death.
- It is implicated in cellular homeostasis and disease, particularly cancer.
- Ferroptosis involves mitochondrial dysfunction and lipid peroxidation, crucial for inhibiting cancer progression.
Purpose of the Study:
- To review molecular mechanisms of ferroptosis in various antitumor treatments.
- To explore combinatorial therapeutic effects of ferroptosis inducers with conventional cancer therapies.
- To discuss clinical applications, challenges, and future directions for ferroptosis-driven cancer therapy.
Main Methods:
- Literature review of existing studies on ferroptosis and cancer treatment.
- Analysis of molecular mechanisms linking ferroptosis to chemotherapy, targeted therapy, radiotherapy, and immunotherapy.
- Evaluation of synergistic and drug-resistance reversal effects of combined therapies.
Main Results:
- Ferroptosis induction plays a key role in suppressing cancer growth.
- Combinations of ferroptosis inducers with conventional therapies show synergistic sensitization and drug-resistance reversal.
- Nanotechnology and novel approaches offer new avenues for ferroptosis-based cancer treatment.
Conclusions:
- Ferroptosis is a significant therapeutic target for cancer.
- Combining ferroptosis induction with existing treatments can improve outcomes.
- Future research should focus on overcoming clinical challenges and leveraging new technologies for ferroptosis-driven cancer therapies.
Related Concept Videos
01:16Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
02:56Treatment Resistant Cancers
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...